LexaGene Holdings Inc. (LXXGF)
LexaGene Holdings Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Beverly, MA, US. The stock last traded at $0.08, up 0.00% on the session, giving a market capitalisation of $11.3M. Its beta of 2.04 implies it has historically moved more than the broad market.
LexaGene Holdings Inc. is a biotechnology firm dedicated to the innovation, development, and market release of systems designed for identifying pathogens. Its core offering is MiQLab, an automated pathogen detection platform poised to revolutionize how pathogens are detected in diverse fields, including veterinary and human clinical diagnostics, food and water safety analysis, and other life science applications. This cutting-edge system can be deployed directly where samples are collected, providing exceptional user-friendliness, precise sensitivity, and a broad scope for pathogen identification. The company was established in 2007 and operates from its headquarters in Beverly, Massachusetts.
LexaGene Holdings Inc. is most often compared with the following Healthcare names: